In addition, although the reported impacts of the pandemic on diabetes management vary by country and insulin treatment technology, multiple countries have reported an increase in diabetic ketoacidosis frequency [12,13] and suboptimal glycemic variability [14,15]. Here, INS is linked to diabetes mellitus.